Allscripts Healthcare Solutions Inc (MDRX.A)
13.94USD
22 May 2013
$-0.12 (-0.85%)
$14.06
$14.06
$14.08
$13.94
4,974
18,316
$14.19
$8.86
MDRX.A
About
Overall
| Beta: | 1.26 |
| Market Cap (Mil.): | $2,492.32 |
| Shares Outstanding (Mil.): | 177.26 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| MDRX.A | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 76.80 | 35.13 |
| EPS (TTM): | -0.11 | -- | -- |
| ROI: | -0.93 | 4.25 | 18.83 |
| ROE: | -1.31 | 9.07 | 19.68 |
BRIEF-Allscripts down 5.8 percent in extended trade
NEW YORK, May 9 - Allscripts Healthcare Solutions Inc : * Down 5.8 percent to $13.05 in extended trade after Q1 results
Allscripts buys two health software firms to reinvent product line
- Allscripts Healthcare Solutions acquired health management software and service providers dbMotion and Jardogs LLC under a wider plan to invest about $500 million this year, as it seeks to breathe new life into its product portfolio after dropping plans to sell itself.
Allscripts buys Israel's medical software maker dbMotion-report
TEL AVIV, March 5 - Allscripts Healthcare Solutions is acquiring Israeli healthcare software provider dbMotion for $235 million, the Calcalist financial news website said on Tuesday.
TEXT-S&P says new Allscripts Healthcare CEO won't affect rating
Dec 21 - Standard & Poor's Ratings Services said today that Chicago-based Allscripts Healthcare Solutions Inc.'s BB+/Negative/--) announcement that Paul Black has been named the new President and CEO, replacing Glen Tullman, CEO, and Lee Shapiro, President, does not affect our ratings on Allscripts. The outlook remains negative. The negative outlook reflects our expectation of potential downside volatility in near term operating results given senior management and board turnover since Ap
Allscripts shares plunge as company drops plan for sale
- Shares of Allscripts Healthcare Solutions Inc fell as much as 17 percent on Thursday after the company abandoned plans to sell itself and instead introduced new management to run the company as an independent entity.
UPDATE 1-Allscripts shares plunge as company drops plan for sale
* Stock falls as much as 17 pct after announcement (Updates with background)
Allscripts shares plunge as company drops plan for sale
Dec 20 - Shares of Allscripts Healthcare Solutions Inc fell nearly 17 percent on Thursday after the company abandoned plans to sell itself and instead introduced new management to run the company as an independent entity.
Allscripts names new CEO to spearhead recovery
- Embattled healthcare technology firm Allscripts named its board member and former chief operating officer of rival Cerner Corp Paul Black as its CEO, replacing Glen Tullman, and said it ended a review of strategic alternatives.
Allscripts names new CEO as strategic review ends
- Allscripts Healthcare Solutions Inc named board member Paul Black as its chief executive officer, replacing Glen Tullman, and said it ended a review of its strategic alternatives.
UPDATE 1-Allscripts names new CEO as strategic review ends
Dec 19 - Allscripts Healthcare Solutions Inc named board member Paul Black as its chief executive officer, replacing Glen Tullman, and said it ended a review of its strategic alternatives.
Competitors
| Price | Change | |
|---|---|---|
| General Electric Company (GE.N) | $23.86 | +0.20 |
| McKesson Corporation (MCK.N) | $117.55 | -0.86 |
| Siemens AG (SIEGn.DE) | €82.29 | +1.06 |
| Cerner Corporation (CERN.OQ) | $96.25 | -1.38 |
| Quality Systems, Inc. (QSII.OQ) | $18.82 | -0.04 |
| athenahealth, Inc (ATHN.OQ) | $85.21 | -1.16 |
| Greenway Medical Technologies, Inc. (GWAY.N) | $11.70 | -0.15 |
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Wright Reports
|
$483.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Market Edge
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
